FDA announces shortage of products used for neurosurgery, microsurgery expected to continue remainder of 2026

May 07, 2026 - 02:30 PM
fda-product-update

The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to supplier issues, and expects the issue to continue through the end of the year. The agency said a manufacturing disruption in supplying the products is expected to impact patient care and could require adjustments to clinical management of patients receiving neurosurgery or microsurgery. The FDA recommended a list of strategies for health care providers to consider which would conserve the use of neurosurgical patties, sponges and strips when possible.

The FDA said that Medline Industries sent a customer letter March 13, saying that higher-than-expected endotoxin levels were identified on Medline-branded neurosurgical pattie products, suggesting that out-of-specification endotoxin levels may be present in on-market products. Using the product may result in health hazards that could necessitate medical or surgical intervention, such as febrile response and/or local transient inflammation, hypotension or nausea, the FDA said.

Related News Articles

Headline
HHS establishes quarterly PPE forecast 
The Department of Health and Human Services Sept. 18 announced the launch of a new personal protective equipment forecast to identify, consolidate and publish…
Headline
CMS moratorium on durable medical equipment supplier enrollment expires
The Centers for Medicare & Medicaid Services’ six-month moratorium on the enrollment of new durable medical equipment, prosthetics, orthotics and supply…
Headline
USTR implements new tariffs on 60 trading partners
The U.S. Trade Representative yesterday announced it is implementing a 10% or 12.5% tariff on 60 trading partners, which became effective today. These…
Headline
FDA proposes drug registration changes to boost supply chain transparency
The Food and Drug Administration July 10 released a proposed rule that would modernize drug establishment registration requirements, with implications for…
Headline
AHA comments on proposed tariffs on medications, medical devices
The AHA today sent a letter to the Office of the United States Trade Representative to ask that medications, medical devices and other healthcare…
Headline
FDA says shortage of breast biopsy needles expected to last until 2027 
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…